Taken together our results support the notion that PPARγ represents a valuable target for pharmacologic intervention that when neutralized during bacterial infection would lead to preferential enhancement of immune-mediated clearance of intracellular bacteria such as L. monocytogenes without accompanying immunopathology to infected organs like the liver. This evidence concerns the gene PPARG and bacterial infectious disease.